These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22098077)

  • 1. Urotensin II levels in patients with chronic kidney disease and kidney transplants.
    Hursitoglu M; Tukek T; Cikrikcioglu MA; Kara O; Kazancioglu R; Ozkan O; Cakirca M; Akdogan F; Gundogan E; Aydin S; Beycan I; Gursu M; Dogan S; Erek A
    Ups J Med Sci; 2012 Mar; 117(1):22-7. PubMed ID: 22098077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Urotensin II levels in children and adolescents with chronic kidney disease: a single-centre study.
    Garoufi A; Drapanioti S; Marmarinos A; Askiti V; Mitsioni AJ; Mila M; Grigoriadou G; Georgakopoulos D; Stefanidis CJ; Gourgiotis D
    BMC Nephrol; 2017 Mar; 18(1):113. PubMed ID: 28359257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentration of urotensin II is raised in hypertension.
    Cheung BM; Leung R; Man YB; Wong LY
    J Hypertens; 2004 Jul; 22(7):1341-4. PubMed ID: 15201550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urotensin II: a cardiovascular and renal update.
    Zoccali C; Mallamaci F
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):199-204. PubMed ID: 18277155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure.
    Dschietzig T; Bartsch C; Pregla R; Zurbrügg HR; Armbruster FP; Richter C; Laule M; Romeyke E; Neubert C; Voelter W; Baumann G; Stangl K
    Regul Pept; 2002 Dec; 110(1):33-8. PubMed ID: 12468107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of urotensin II in patients on dialysis.
    Totsune K; Takahashi K; Arihara Z; Sone M; Satoh F; Ito S; Kimura Y; Sasano H; Murakami O
    Lancet; 2001 Sep; 358(9284):810-1. PubMed ID: 11564491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential extraction and immunoluminometric assay of Urotensin II and Urotensin-related peptide in heart failure.
    Jani PP; Narayan H; Ng LL
    Peptides; 2013 Feb; 40():72-6. PubMed ID: 23270674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma urotensin II in heart failure.
    Richards AM; Nicholls MG; Lainchbury JG; Fisher S; Yandle TG
    Lancet; 2002 Aug; 360(9332):545-6. PubMed ID: 12241661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal impairment, hypertension and plasma urotensin II.
    Mosenkis A; Kallem RR; Danoff TM; Aiyar N; Bazeley J; Townsend RR
    Nephrol Dial Transplant; 2011 Feb; 26(2):609-14. PubMed ID: 20621933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between human urotensin II and essential hypertension--a 1:1 matched case-control study.
    Peng H; Zhang M; Cai X; Olofindayo J; Tan A; Zhang Y
    PLoS One; 2013; 8(12):e81764. PubMed ID: 24339964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma urotensin-2 level and Thr21Met but not Ser89Asn polymorphisms of the urotensin-2 gene are associated with migraines.
    Geyik S; Ergun S; Kuzudişli S; Şensoy F; Temiz E; Altunışık E; Korkmaz M; Dağlı H; Kul S; Akçalı A; Neyal AM
    J Headache Pain; 2016; 17():36. PubMed ID: 27090416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urotensin II and biomarkers of endothelial activation and atherosclerosis in end-stage renal disease.
    Mallamaci F; Cutrupi S; Pizzini P; Tripepi G; Zoccali C
    Am J Hypertens; 2006 May; 19(5):505-10. PubMed ID: 16647624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the UTS2 gene polymorphisms and plasma Urotensin-II levels in breast cancer.
    Yumrutas O; Oztuzcu S; Büyükhatipoglu H; Bozgeyik I; Bozgeyik E; Igci YZ; Bagis H; Cevik MO; Kalender ME; Eslik Z; Arslan A
    Tumour Biol; 2015 Jun; 36(6):4427-32. PubMed ID: 25604143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of the vasoactive peptide urotensin II in patients with acute coronary syndrome and stable coronary artery disease.
    Al Kindi H; Hafiane A; You Z; Albanese I; Pilote L; Genest J; Schwertani A
    Peptides; 2014 May; 55():151-7. PubMed ID: 24642358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma urotensin II as a marker for severity of rheumatic valve disease.
    Ozer O; Davutoglu V; Ercan S; Akcay M; Sari I; Sucu M; Celik A; Aksoy N; Cicek H; Al B
    Tohoku J Exp Med; 2009 May; 218(1):57-62. PubMed ID: 19398874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum urotensin II levels in patients with non-dipper hypertension.
    Erbay AR; Meric M; Alacam H; Zengin H; Akin F; Okuyucu A; Yuksel S; Soylu K; Gedikli O
    Clin Exp Hypertens; 2013; 35(7):506-11. PubMed ID: 23301552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urotensin-II levels in acute coronary syndromes.
    Joyal D; Huynh T; Aiyar N; Guida B; Douglas S; Giaid A
    Int J Cardiol; 2006 Mar; 108(1):31-5. PubMed ID: 16516696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G; Cutrupi S; Pizzini P; Malatino L
    Kidney Int; 2006 Apr; 69(7):1253-8. PubMed ID: 16508659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urotensin II in the development and progression of chronic kidney disease following ⅚ nephrectomy in the rat.
    Eyre HJ; Speight T; Glazier JD; Smith DM; Ashton N
    Exp Physiol; 2019 Mar; 104(3):421-433. PubMed ID: 30575177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of cerebrospinal fluid and plasma urotensin II concentrations in normotensive and hypertensive patients undergoing urological surgery during spinal anesthesia: a pilot study.
    Thompson JP; Watt P; Sanghavi S; Strupish JW; Lambert DG
    Anesth Analg; 2003 Nov; 97(5):1501-1503. PubMed ID: 14570674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.